volume 44 issue 6 pages 1149-1157

Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans

Martin Feelisch 1
Karl Schönafingeri 2
Hike Noack 1
2
 
Department of Medicinal Chemistry, Cassella AG, Frankfurt am Main, Federal Republic of Germany
Publication typeJournal Article
Publication date1992-09-01
scimago Q1
wos Q1
SJR1.599
CiteScore9.4
Impact factor5.6
ISSN00062952, 18732968
Biochemistry
Pharmacology
Abstract
Furoxans (1,2,5-oxadiazole-2-oxides) are widely used in organic chemistry as intermediate compounds for the synthesis of various heterocycles. Despite the fact that some furoxans have been found to possess remarkable biological activities, up to now no systematic study on their mode of action has been reported. The aim of the present study was to investigate the molecular mode of the vasodilator action of furoxans. Furoxans, but not the corresponding furazans, concentration-dependently increased coronary flow in an isolated working rat heart preparation. This effect was blunted upon coinfusion with méthylane blue. All tested furoxans were demonstrated to increase potently the activity of soluble guanylate cyclase. Enzyme stimulation was found to be mediated by the generation of nitric oxide (NO) following chemical reaction of the furoxans with sulfhydryl groups of low molecular weight thiols and proteins. Furoxans are thus prodrugs which increase the level of cyclic GMP via formation of NO and may therefore be classified as nitrovasodilators. Along with the generation of NO, nitrite and nitrate ions and S -nitrosothiols were formed. The rates of formation of these metabolites, however, did not appear to be related to enzyme stimulation. A tentative reaction scheme that fits the obtained experimental data is proposed. Recently reported cytotoxic, mutagenic, immunosuppressive and anticancer effects of furoxans are discussed in the light of their ability to release NO upon reaction with thiols.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
Journal of Medicinal Chemistry
9 publications, 6.52%
European Journal of Medicinal Chemistry
8 publications, 5.8%
British Journal of Pharmacology
7 publications, 5.07%
Mendeleev Communications
5 publications, 3.62%
Tetrahedron
4 publications, 2.9%
Nitric Oxide - Biology and Chemistry
4 publications, 2.9%
Tetrahedron Letters
3 publications, 2.17%
Russian Journal of Organic Chemistry
3 publications, 2.17%
Bioorganic and Medicinal Chemistry Letters
3 publications, 2.17%
Molecules
3 publications, 2.17%
Bioorganic Chemistry
3 publications, 2.17%
Journal of Heterocyclic Chemistry
3 publications, 2.17%
Chemistry of Heterocyclic Compounds
2 publications, 1.45%
Journal of Organic Chemistry
2 publications, 1.45%
Organic Letters
2 publications, 1.45%
Journal of Controlled Release
2 publications, 1.45%
Il Farmaco
2 publications, 1.45%
Russian Chemical Reviews
2 publications, 1.45%
Journal of Biological Chemistry
2 publications, 1.45%
Archiv der Pharmazie
2 publications, 1.45%
Asian Journal of Organic Chemistry
2 publications, 1.45%
Chemical Biology and Drug Design
2 publications, 1.45%
Beilstein Journal of Organic Chemistry
1 publication, 0.72%
European Journal of Pharmacology
1 publication, 0.72%
Journal of Pharmacology and Experimental Therapeutics
1 publication, 0.72%
Current Organic Chemistry
1 publication, 0.72%
Canadian Journal of Chemistry
1 publication, 0.72%
Journal of Ocular Pharmacology and Therapeutics
1 publication, 0.72%
Microbiology
1 publication, 0.72%
1
2
3
4
5
6
7
8
9

Publishers

5
10
15
20
25
30
35
40
Elsevier
40 publications, 28.99%
Wiley
25 publications, 18.12%
American Chemical Society (ACS)
18 publications, 13.04%
Springer Nature
11 publications, 7.97%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
5 publications, 3.62%
Pleiades Publishing
4 publications, 2.9%
Royal Society of Chemistry (RSC)
4 publications, 2.9%
MDPI
3 publications, 2.17%
Taylor & Francis
3 publications, 2.17%
Bentham Science Publishers Ltd.
2 publications, 1.45%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
2 publications, 1.45%
American Society for Biochemistry and Molecular Biology
2 publications, 1.45%
Georg Thieme Verlag KG
2 publications, 1.45%
Beilstein-Institut
1 publication, 0.72%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.72%
Canadian Science Publishing
1 publication, 0.72%
Mary Ann Liebert
1 publication, 0.72%
Microbiology Society
1 publication, 0.72%
Pharmaceutical Society of Japan
1 publication, 0.72%
World Scientific
1 publication, 0.72%
Pharmaceutical Society of Korea
1 publication, 0.72%
Walter de Gruyter
1 publication, 0.72%
1 publication, 0.72%
Hindawi Limited
1 publication, 0.72%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.72%
The Society of Synthetic Organic Chemistry, Japan
1 publication, 0.72%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
138
Share
Cite this
GOST |
Cite this
GOST Copy
Feelisch M., Schönafingeri K., Noack H. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans // Biochemical Pharmacology. 1992. Vol. 44. No. 6. pp. 1149-1157.
GOST all authors (up to 50) Copy
Feelisch M., Schönafingeri K., Noack H. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans // Biochemical Pharmacology. 1992. Vol. 44. No. 6. pp. 1149-1157.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/0006-2952(92)90379-W
UR - https://doi.org/10.1016/0006-2952(92)90379-W
TI - Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans
T2 - Biochemical Pharmacology
AU - Feelisch, Martin
AU - Schönafingeri, Karl
AU - Noack, Hike
PY - 1992
DA - 1992/09/01
PB - Elsevier
SP - 1149-1157
IS - 6
VL - 44
PMID - 1358072
SN - 0006-2952
SN - 1873-2968
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1992_Feelisch,
author = {Martin Feelisch and Karl Schönafingeri and Hike Noack},
title = {Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans},
journal = {Biochemical Pharmacology},
year = {1992},
volume = {44},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/0006-2952(92)90379-W},
number = {6},
pages = {1149--1157},
doi = {10.1016/0006-2952(92)90379-W}
}
MLA
Cite this
MLA Copy
Feelisch, Martin, et al. “Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.” Biochemical Pharmacology, vol. 44, no. 6, Sep. 1992, pp. 1149-1157. https://doi.org/10.1016/0006-2952(92)90379-W.